Delivery Order SPE2DB22D1106-SPE2DB24FEAN5
- Not listed
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TROKENDI XR 200 MG CAPSULE 30S. The contract has a potential value of $1,108.13 and a completion date of February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not set aside for any particular business type. The award is under an Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,064.50 firm fixed-price delivery order is for the supply of 4566177898 TROKENDI XR 100 MG CAPSULE 30S, with an ultimate completion date of October 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order valued at $2,311.17 for the supply of TROKENDI XR 200 MG CAPSULE 30S. It is a firm fixed price contract with a completion date of July 18, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00 and...
- This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,704.63, is for the delivery of TROKENDI XR 100 MG CAPSULE 30S, a pharmaceutical product. The contract is a Delivery Order type with a Firm Fixed Price pricing structure, and has an ultimate completion date of April 1, 2025. There is no set-aside designation mentioned for this award....
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The $1,076.16 contract is for the delivery of Trokendi XR 25 mg capsules to support military treatment programs and medical facilities. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the...
- This is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA). The contract is for the supply of TROKENDI XR 100 MG CAPSULE 30S, a pharmaceutical product, with a potential value of $2,147.03. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and is responsible for delivering the pharmaceutical products to support military treatment...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $547.74 delivery order by the Defense Logistics Agency to provide 4562144347 TROKENDI XR 100 MG CAPSULE 30S. The firm fixed price order is being carried out under an existing DLA contract vehicle and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period concluding on September 13, 2023. As the prime contractor, Amerisourcebergen will deliver the...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,263.18 firm fixed-price delivery order is for the supply of TROKENDI XR 100 MG capsules. The contract has an ultimate completion date of January 2, 2025. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on April 23, 2026, for TROKENDI XR 100 mg capsules with a ceiling value of $3,371.81 under a single-award indefinite delivery contract with the DLA Troop Support Medical program. Place of performance is Conshohocken, PA. The order is firm fixed-price with an ultimate completion date of April 24, 2026. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor...
- This federal contract award is a delivery order for the pharmaceutical product Trokendi XR 50 mg capsules awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,208.55 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) on January 27, 2025 and has an ultimate completion date of January 28, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEAN5Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply TROKENDI XR 200 MG capsules. The order has a potential value of $2,506.29 and a completion date of February 16, 2024. Amerisourcebergen Drug Corp is the prime contractor and the contract does not have a set-aside designation. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. Firm fixed price task orders issued under this IDC have enabled the provision of a comprehensive range of medications and healthcare materials to military treatment programs and medical facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 2/15/24 |